FDA Adverse Event Injury Summary report: N

GORE® EXCLUDER® AAA ENDOPROSTHESIS

MDR report key: 7136857 · Received December 20, 2017

Report

Report Number
2017233-2017-00669
Event Type
Injury
Date Received
December 20, 2017
Date of Event
January 1, 2012
Report Date
January 19, 2018
Manufacturer
W.L. GORE & ASSOCIATES
Product Code
MIH
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

USERS ARE MADE AWARE OF THE RISKS ASSOCIATED WITH TYPE II ENDOLEAKS IN THE IFU AND ARE INSTRUCTED TO CONSIDER THE RISKS AND BENEFITS DISCUSSED IN THE IFU FOR EACH PATIENT BEFORE USING THE DEVICES.

Additional Manufacturer Narrative · 1

THE REVIEW OF THE MANUFACTURING PAPERWORK VERIFIED THAT THIS LOT MET ALL PRE-RELEASE SPECIFICATIONS. (B)(4).

Additional Manufacturer Narrative · 1

(B)(6). (B)(4).

Description of Event or Problem · 1

ON (B)(6) 2011, THE PATIENT UNDERWENT ENDOVASCULAR TREATMENT OF AN ABDOMINAL AORTIC ANEURYSM WITH THREE GORE® EXCLUDER® AAA ENDOPROSTHESES (PXT261414/8956838, PXC161000/9081813, AND PXC181200/8738193). ON AN UNKNOWN DATE, 2012, TYPE II ENDOLEAK WAS REPORTED. COILING FOR TYPE II ENDOLEAK WAS PERFORMED. ON (B)(6) 2017, GORE® EXCLUDER® AAA ENDOPROSTHESES WERE REPLACED BY ARTIFICIAL BLOOD VESSEL SINCE THE SHAPE OF ANEURYSM AND VESSEL WERE NOT GOOD FOR BLOOD FLOW.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
912279 GORE® EXCLUDER® AAA ENDOPROSTHESIS MIH W.L. GORE & ASSOCIATES 8956838

Patients

Seq Age Sex Outcome Treatment
1 87 YR Hospitalization| R